CNR1

CNR1

CNR1 Overview

Molecule Name
Cannabinoid CB1 receptor
Synonyms
CNR1,cannabinoid receptor 1,CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR
Drug Development Progress
Drugs in Clinical Trials38
Approved Drugs2
Highest Development StageApproved
Target Synonym
Cannabinoid Receptor 1 (Brain),CNR1,Cannabinoid Receptor 1,CANN6,CB-R,CNR,CB1,Central Cannabinoid Receptor,CB1K5,CB1A,CB1R,Receptor, Cannabinoid, CB1
Background
This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene.

CNR1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Dronabinol(AXIM Biotechnologies)Phase 3 ClinicalAxim Biotechnologies Inc
Anorexia Nervosa; Cachexia; Child Nutrition Disorders; Nausea; Neoplasms; Nutrition Disorders; Sarcopenia; Vomiting
Details
Cannabidiol soft-gel (Avecho Biotechnology)CBD-TPMPhase 3 ClinicalAvecho Biotechnology Ltd
Sleep Initiation and Maintenance Disorders
Details
Cannabidiol Gel (Zynerba)ZYN002; ZYN-002Phase 3 ClinicalZynerba Pharmaceuticals Inc
DiGeorge Syndrome; Fragile X Syndrome
Details
AdezunapAP-707Phase 3 ClinicalCannaXan GmbH
Accidental Injuries; Back Pain; Brachial Plexus Neuropathies; Brain Injuries, Traumatic; Chronic Pain; Diabetes Mellitus; Diabetic Neuropathies; Diabetic peripheral neuropathy; Low Back Pain; Multiple Sclerosis; Neuralgia; Pain; Pain, Postoperative; Paraplegia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Phantom Limb; Somatoform Disorders; Stroke
Details
Dronabinol(Vertanical)VER-01Phase 3 ClinicalVertanical GmbH
Low Back Pain
Details
cannabidiol (Cardiol Therapeutics)Phase 3 ClinicalCardiol Therapeutics Inc
Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Myocarditis; Pericarditis
Details
SelonabantV-24343; ANEB-001; VER-24343Phase 2 ClinicalVernalis Plc
Obesity; Poisoning
Details
11C-MePPEP11C-MePPEPPhase 2 ClinicalEli Lilly And Company
Obesity; Substance-Related Disorders
Details
AX-1602AX-1602Phase 2 ClinicalAxim Biotechnologies Inc
Dermatitis, Atopic; Psoriasis; Vitiligo
Details
NimacimabRYI-018; RYI-028; JNJ-2463Phase 2 ClinicalBird Rock Bio Inc
Diabetic Gastroparesis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Renal Insufficiency, Chronic
Details
ART-2713NEO-1940; ART-2713; ART27.13; AZD-1940Phase 2 ClinicalAstrazeneca Plc, Neomed Inc, Pfizer Inc
Anorexia; Cachexia; Low Back Pain; Pain; Weight Loss
Details
AEF-0217AEF-0217Phase 2 ClinicalAelis Farma
Down Syndrome
Details
MonlunabantS-MRI-1891; (-)-MRI-1891; NN9440–INV-202; INV-202; MRI-1891Phase 2 ClinicalInversago Pharma Inc
Diabetic Nephropathies; Metabolic Diseases; Metabolic Syndrome; Obesity
Details
Cannabidiol (Ananda Scientific)A-1002-N5S; A1002N5SPhase 2 ClinicalAnanda Scientific Inc
Chronic Pain; Opioid-Related Disorders; Stress Disorders, Post-Traumatic; Tobacco Smoking; Tobacco Use Disorder
Details
Cannabidiol (Biopharmaceutical Research Company)BRC-001Phase 2 ClinicalBiopharmaceutical Research Company
Breast Neoplasms; Carcinoma, Ductal, Breast
Details
C20T5C20T5Phase 2 ClinicalMurdoch Childrens Research Institute
Details
C12T12C12T12Phase 2 ClinicalMurdoch Childrens Research Institute
Details
SuvadronabinolTHC-VHS-NEC; SBI-100; NB-1111; Sb-100 OE; SBI-100 OE; THCVHS; THCVHS-N; THCVHS-NE; UM-5050Phase 2 ClinicalUniversity Of Mississippi
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
IGC-AD1IGC-AD1Phase 2 ClinicalUniversity Of South Florida
Alzheimer Disease; Dementia; Psychomotor Agitation
Details
LixosiconeAEF-0117Phase 2 ClinicalAelis Farma, National Institute On Drug Abuse
Marijuana Abuse
Details
ZYN-001ZYN-001Phase 1 ClinicalZynerba Pharmaceuticals
Fibromyalgia; Neuralgia
Details
TetrahydrocannabivarinGWP-42004; THCV; O-4394; DELTA9-THCV; GW-42004Phase 1 ClinicalGw Pharmaceuticals Plc
Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hyperglycemia; Metabolic Syndrome; Obesity, Morbid
Details
Cannabidiol/hydroxychloroquineIHL-675A; IHL-675Phase 1 ClinicalIncannex Healthcare Ltd
Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult
Details
ZevaquenabantMRI-1867; (S)-MRI-1867; INV-101Phase 1 ClinicalNational Institutes Of Health
Scleroderma, Systemic
Details
Cannabidiol (Artelo Biosciences)ART-12.11; ART12.11; ART-1211Phase 1 ClinicalArtelo Biosciences Inc
Anxiety; Depression; Depressive Disorder
Details
S1-221S1-221Phase 1 ClinicalDelphian Therapeutics Australia Pty Ltd
Details
Cannabidiol (Tiamat Australia)MRX-1Phase 1 ClinicalTiamat Australia Pty Ltd
Details
Atorvastatin Calcium Hydrate/CannabidiolPhase 1 ClinicalIndication Bioscience LLC
Coronary Disease; Dyslipidemias
Details
TPT0301TPT-0301; TPT0301Phase 1 ClinicalTetra Pharm Technologies ApS
Chronic Pain
Details
INV-347NN9441; NN-9441; INV-347Phase 1 ClinicalInversago Pharma Inc
Obesity
Details
IPI 201(Isosceles Pharmaceuticals Inc )IPI-201Phase 1 Clinical
Pain, Postoperative
Details
CRB-913CRB-913Phase 1 ClinicalJenrin Discovery LLC
Obesity
Details
GFB-024Phase 1 ClinicalTakeda Pharma
Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Endocrine System Diseases; Kidney Diseases
Details
DBPR-211Phase 1 ClinicalNational Health Research Institutes
Diabetes Mellitus, Type 2
Details
MP-10XMP-10XClinicalMedipure Holdings
Pain
Details
MP-20XMP-20XClinicalMedipure Holdings
Anxiety Disorders; Mood Disorders
Details
Cannabidiol (Receptor Life Sciences)ClinicalReceptor Life Sciences Inc
Autism Spectrum Disorder
Details
Cannabidiol/PalmitoylethanolamideSCI–210; THX-210ClinicalTherapix Biosciences Ltd
Autism Spectrum Disorder; Diabetic Neuropathies
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Cannabidiol/Dronabinoldelta-9-THC/CBD; MPL-001; MPL-005; PPP-011; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT; GW-1000; KL16-012; THC-5ApprovedGw PharmaceuticalsSativex, Qixleef, QIXLEEFTMCanadaCancer Pain; Chronic Pain; Muscle Spasticity; Neuralgia; Multiple Sclerosisnull2005-04-01
Acute Pain; Agitation; Agoraphobia; Anorexia; Anxiety Disorders; Arthritis, Psoriatic; Arthritis, Rheumatoid; Back Pain; Cancer Pain; Cerebral Palsy; Chronic Pain; Corticobasal degeneration; Dementia; Depression; Depressive Disorder, Major; Diabetic Neuropathies; Drug Resistant Epilepsy; Essential Tremor; Genital Diseases, Male; Healthy Aging; Hepatic Insufficiency; Hidradenitis Suppurativa; Huntington Disease; Kidney Diseases; Low Back Pain; Malnutrition; Marijuana Abuse; Marijuana Use; Migraine Disorders; Multiple Sclerosis; Muscle Spasticity; Neck Pain; Neoplasms; Neuralgia; Neuralgia, Postherpetic; Neuromyelitis Optica; Opioid-Related Disorders; Osteoarthritis, Knee; Pain; Panic Disorder; Peripheral Nervous System Diseases; Phobia, Social; Psoriasis; Reflex Sympathetic Dystrophy; Renal Insufficiency; Renal Insufficiency, Chronic; Sciatica; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Social Behavior; Spasm; Spinal Cord Injuries; Squamous Cell Carcinoma of Head and Neck; Stress Disorde
Details
CannabidiolCHI-902; APH-1501; GLA-015; BTX-1503; BTX-1801; GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; PTL-101; BTX-1702; PBX-1308; BRCX-014; LYT-310; GWP-42003ApprovedGw Pharmaceuticals PlcEpidyolex, Cannepil, EpidiolexUnited StatesEpilepsies, Myoclonic; Lennox Gastaut Syndromenull2018-06-25
Acne Vulgaris; Acute Pain; Alcohol Abstinence; Alcoholic Intoxication; Alcoholism; Anemia, Sickle Cell; Anorexia Nervosa; Anxiety; Anxiety Disorders; Appetitive Behavior; Arthralgia; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autism Spectrum Disorder; Autistic Disorder; Azotemia; Behavior, Addictive; Bipolar Disorder; Blepharospasm; Brain Diseases; Brain Injuries, Traumatic; Breast Neoplasms; Bruxism; Burnout, Psychological; Cachexia; Carcinoma, Non-Small-Cell Lung; Carpal Tunnel Syndrome; Central Nervous System Diseases; Child Behavior Disorders; Chronic Pain; Chronic Periodontitis; Chronic Urticaria; Cicatrix; Cognition Disorders; Cognitive Dysfunction; Colitis, Ulcerative; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Corticobasal degeneration; Craving; Crohn Disease; Cystitis, Interstitial; Dentin Sensitivity; Depression; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Driving Under the Influence; Drug Resistant Epilepsy; Dyslipidemias; Dysmenorrhea; Dyspepsia; Eczema;
Details